Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

DocuSign Inc DOCU

DocuSign, Inc. offers electronic signature product, enabling an agreement to be signed electronically on a variety of devices, from virtually anywhere in the world. The Company product offerings, include the electronic signature product, which allow organizations to do business faster with less risk and at a lower cost, while providing a better experience for customers. It also offers contract lifecycle management software that automates pre- and post-signature workflows. This includes automatically generating an agreement from data in other systems, supporting negotiation workflows, verifying identities, enabling remote online notarization, collecting payment after signatures, and using artificial intelligence (AI) to analyze a collection of agreements for risks and opportunities. Its products include eSignature, Contract Lifecycle Management (CLM), Gen for Salesforce, Identify and Monitor. Its Document Generation streamlines the process of generating new, custom agreements.


NDAQ:DOCU - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Melany4on Apr 18, 2022 2:23am
143 Views
Post# 34609140

FSD Pharma Inc: Lucid MS Video

FSD Pharma Inc: Lucid MS Video


FSD Pharma is delighted to announce pre-clinical findings indicating the efficacy of Lucid-MS, its flagship medication candidate, in treating Multiple Sclerosis. Lucid-MS's therapeutic potential is an industry first, and we'd like to provide visual evidence of functional recovery in pre-clinical individuals in this video!

<< Previous
Bullboard Posts
Next >>